The massive share overhang (~261% of current float) creates significant downside risk as selling shareholders can begin trading immediately. Monitor for insider sales and any subsequent capital raises; expect elevated volatility and potential price declines until the overhang is absorbed.
Price Chart
Executive Summary
Lifeward Ltd. filed an S-3 registration statement on April 27, 2026, registering 7,256,474 ordinary shares for resale by selling shareholders Oramed Pharmaceuticals and Creative Value Capital LP. These shares were issued in connection with the strategic acquisition of Oratech that closed on March 25, 2026. The company will not receive any proceeds, and the shares represent approximately 261% of current shares outstanding, creating a massive potential overhang. The company's auditor has expressed substantial doubt about its ability to continue as a going concern.
Key Financial Metrics
Key Facts
- Registration of 7,256,474 ordinary shares for resale by selling shareholders
- Shares represent ~261% of the 2,778,585 shares outstanding as of April 24, 2026
- Maximum aggregate offering price of $50,505,059 based on a $6.96 reference price
- Company will not receive any proceeds from this offering
- Auditor's report includes a going concern explanatory paragraph for the fiscal year 2025
- Strategic acquisition of Oratech closed on March 25, 2026; shares issued as part of that transaction
Financial Impact
Up to $50.5 million in potential selling pressure against an $11 million market cap
Risk Factors
- Potential for substantial stock price decline due to selling pressure from the resale of over 7 million shares
- Going concern risk highlighted by the auditor
- Dilution of existing shareholders' stakes if warrants are exercised
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 7 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| S-3 Filing (Primary) | 0001178913-26-002253 |
| Exhibit: exhibit_107.htm | 0001178913-26-002253 |
| Exhibit: exhibit_5-1.htm | 0001178913-26-002253 |
| Exhibit: exhibit_23-1.htm | 0001178913-26-002253 |
| Document: 0001178913-26-002253-index-headers.html | 0001178913-26-002253 |
| Document: 0001178913-26-002253-index.html | 0001178913-26-002253 |
| Document: 0001178913-26-002253.txt | 0001178913-26-002253 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 14, 2026 7w ago | 8-K | $7.45 $7.11 | ▼ −4.56% | ▼ −2.57% | $5.85 (−21.48%) |
Aug 14, 2026 7w ago | Press Release | $7.45 $7.11 | ▲ +4.56% | ▲ +2.57% | $5.85 (+21.48%) |
Aug 11, 2026 7w ago | EFFECT | $7.57 $7.40 | ▲ +2.18% | ▲ +1.12% | $5.85 (+22.67%) |
Aug 7, 2026 8w ago | Press Release | $7.69 $6.98 | ▼ −9.17% | ▼ −8.78% | $5.85 (−23.88%) |
May 19, 2026 19w ago | 8-K | $6.40 $6.98 | ▲ +9.06% | ▲ +8.08% | $5.85 (−8.59%) |
May 15, 2026 20w ago | 8-K | $6.70 $6.96 | ▼ −3.81% | ▼ −1.69% | $5.85 (+12.69%) |
May 15, 2026 20w ago | Press Release | $6.70 $6.96 | ▼ −3.81% | ▼ −1.69% | $5.85 (+12.69%) |
May 13, 2026 20w ago | EFFECT | $6.63 $6.80 | ▼ −2.56% | ▼ −3.18% | $5.85 (+11.76%) |
May 11, 2026 20w ago | Press Release | $6.40 $6.98 | ▲ +9.09% | ▲ +9.40% | $5.85 (−8.59%) |
Apr 27, 2026 22w ago | S-3 | $7.09 $6.98 | ▲ +1.55% | ▲ +7.02% | $5.85 (+17.49%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access